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TH17 cells exemplify environmental immune adaptation: they can acquire both a pathogenic
and an anti-inflammatory fate. However, it is not known whether the anti-inflammatory fate is
merely a vestigial trait, or whether it serves to preserve the integrity of the host tissues. Here
we show that the capacity of TH17 cells to acquire an anti-inflammatory fate is necessary to
sustain immunological tolerance, yet it impairs immune protection against S. aureus. Addi-
tionally, we find that TGF-β signalling via Smad3/Smad4 is sufficient for the expression of the
anti-inflammatory cytokine, IL-10, in TH17 cells. Our data thus indicate a key function of TH17
cell plasticity in maintaining immune homeostasis, and dissect the molecular mechanisms
explaining the functional flexibility of TH17 cells with regard to environmental changes.
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The consequences of dysfunctional immune adaptation areclear: the immune cells either fail to mount a protectiveresponse to lethal infections, or they overreact to non-
harmful antigens and in doing so, induce disparate immune
mediated inflammatory diseases (IMIDs). It is therefore both
fundamentally and clinically relevant to reveal the molecular
mechanisms underlying this phenomenon of immune adaptation.
TH17 cells—a subset of CD4+ T cells—exemplify immune
adaptation. On the one hand, TH17 cells can have a full effector
function protecting the host from pathogens with the associated
risk of developing IMIDs1–5. On the other hand, TH17 cells can
also acquire an anti-inflammatory fate characterized by secretion
of the anti-inflammatory cytokine, IL-106–8. However, the rele-
vance of this TH17 anti-inflammatory fate and the consequences
of its impairment have not yet been fully explored. TH17 cells are
abundant in the intestine6, but it remains to be tested whether by
acquiring an anti-inflammatory fate, they contribute to intestinal
immune homeostasis by blocking the development of a patho-
logical response and preserving the tissue integrity. Furthermore,
whether this anti-inflammatory fate negatively impacts TH17
mediated immunity to pathogens is also unknown.
Finally, the exact molecular mechanism behind this cellular
adaptation also remains to be clarified. Even though the key
molecular pathways for the differentiation of CD4+ T cells into
TH17 cells have been studied extensively9–12, investigation into
the mechanisms that promote the anti-inflammatory fate of
mature TH17 cells has just begun7,13–16. On the basis of in vitro
screenings, we proposed that TGF-β controls the expression of
IL-10 in CD4+ T cells during their in vitro differentiation into
TH17 cells7,17. However, whether TGF-β also plays a key role
in vivo and on already matured TH17 cells, and through which
molecular signalling, remain to be studied.
It is known that upon engagement of TGF-β with TGFBR1/R2
on CD4+ T cells, TGFBR2 trans phosphorylates TGFBR1, which
propagates signalling by phosphorylating Smad2 and Smad3.
Once Smad2 and Smad3 form a heteromeric complex with the
common mediator Smad4, they translocate to the nucleus to
trans-activate several genes. It has been shown that while Smad2
promotes RORγt activity (i.e. the key transcriptional factor of
TH17 cell differentiation), Smad3 impairs it18,19. Furthermore,
Smad4 and SKI protein bind together and repress the Rorγt
promoter, thus when Smad4 gene is deleted from CD4+ T cells,
IL-6 can induce TH17 cells without TGF-β2. Interestingly, in
embryonic stem cells, Smad2 and Smad3 complex cannot access
the target genes without TIF1-γ20. Therefore, TIF1-γ is con-
sidered an alternative pathway to Smad4. Indeed, Smad2/Smad3-
TIF1-γ complex controls the differentiation of hematopoietic
stem/progenitor cells in response to TGF-β, while Smad2/3-
Smad4 complex regulates the proliferation of those cells21. Recent
data suggest that the deletion of Tif1g in CD4+ T cells decreases
the expression of IL-17A and increases IL-10 while the cells are
differentiating into TH17 cells22. Of note, this latter study is
performed either in vitro or it addresses the role of TIF1-γ during
the differentiation of CD4+ T cells into TH17 cells, rather than
in vivo or on mature TH17 cells. Therefore, the role of TGF-β on
mature TH17 cells and through which pathways TGF-β signals,
are still unclear.
In this study, we find that the anti-inflammatory fate of TH17
cells contributes to maintaining intestinal immune homeostasis.
In addition, our data show that the anti-inflammatory fate of
TH17 cells impairs an effective immune response to S. aureus, but
is essential to control the resolution of the intestinal inflamma-
tion. Furthermore, we show that all this is orchestrated by TGF-β
via Smad3 and Smad4 signalling and not via TIF1-γ. Finally, we
extended part of these findings to human biology. Together, these
observations broaden our understanding about how late fate
decision of TH17 cells is controlled and about the physiological
implications behind TH17 plasticity.
Results
TH17 derived IL-10 contributes to intestinal homeostasis.
We previously showed that some TH17 cells can express IL-10
(IL-10+ TH17) and eventually fully convert into bona fide
TR1 cells (TR1exTH17): the anti-inflammatory fate of TH17 cells6,7.
Of note, the identity of these TR1exTH17 cells has been previously
shown at both the transcriptional and functional levels7. How-
ever, the spatial distribution of these different cell statuses (i.e. IL-
10+ TH17 and TR1exTH17 cells) remained to be defined. We used
the Fate+ (Il17aCre/Katushka, Rosa26-STOPFlox/Flox YFP (R26YFP),
Il10eGFP, Foxp3RFP) mice and assessed the presence of TH17
(Foxp3RFP− IL-17AKatushka+ IL-10eGFP− R26YFP+), IL-10+ TH17
cells (Foxp3RFP− IL-17AKatushka+ IL-10eGFP+ R26YFP+)
and TR1exTH17 cells (Foxp3RFP− IL-17AKatushka− IL-10eGFP+
R26YFP+) in lymphoid and in intestinal tissues. We observed that
the majority of these two TH17-derived IL-10 producing cell
populations (i.e. IL-10+ TH17 cells and TR1exTH17 cells) reside in
the Peyer’s Patches (PP) and in the ileum (Fig. 1a). Considering
that the small intestine and PP host several other types of anti-
inflammatory cells, such as Foxp3+ Treg and TR1 cells, which
also secrete high levels of IL-1023–25, we wondered whether the
anti-inflammatory fate of TH17 cells is redundant for the intest-
inal homeostasis. To this end, we crossed Il17aCre mice with
Il10Flox/Flox and R26YFP mice (from here on referred to as Il17aCre
Il10Flox/Flox) (Supplementary Fig. 1a). First, we confirmed the
efficiency of IL-10 deletion in TH17 cells in vivo and in vitro
(Supplementary Fig. 1b–e). Then we investigated whether
intestinal homeostasis in these mice was altered. Although we did
not observe any obvious intestinal tissue damage microscopically
(Supplementary Fig. 1f), many pro-inflammatory genes such as
Il1b, Il17f, Cxcl1, Ifng and Tnfa are elevated in the intestinal
tissues of Il17aCre Il10Flox/Flox mice, compared to their littermate
control mice (Il17aCre Il10Wt/Wt) under steady state con-
ditions (Fig. 1b). Furthermore, a more detailed cellular analysis
revealed that under steady state conditions, there was an
accumulation of TH17 and TH1/TH17 cells in the small intestine
of the Il17aCre Il10Flox/Flox mice compared to their wild-type lit-
termate controls. Of note, the TH1 cell population was compar-
able in frequency and number between the Il17aCre Il10Flox/Flox
and control mice, suggesting that TH17 cell derived IL-10 has a
specific capacity to regulate TH17 cell expansion in the intestine
(Fig. 1c–e).
Next, we profiled the IL-10 expression in different types of
immune cells to assess the different potential contribution to the
phenotype observed in the Il17aCre Il10Flox/Flox mice. We
observed that more than 90% of the cells that co-express IL-10
and YFP (indicating IL-17A production) in the small intestine are
CD4+ T cells (Supplementary Fig. 1g).
Finally, we tested whether Il17aCre Il10Flox/Flox mice acquired
an extra intestinal spontaneous immune dysregulation, but we
could not observe any immune abnormality in the thymus, spleen
and other peripheral lymphoid organs (Supplementary Fig. 2).
These data reveal the distribution of the IL-10+ TH17 cells and
TR1exTH17 cells along the small intestinal tract. Moreover, these
data suggest that the anti-inflammatory fate of TH17 cells plays a
non-redundant role in maintaining the cellular and molecular
immune homeostasis in the small intestine.
IL-10 deletion in TH17 enhances antibacterial immunity.
We next hypothesized that IL-10 deletion in IL-17A producing
cells may lead to more efficient immunity at the expense
of immunological tolerance. To test this hypothesis, we first used
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a S. aureus infection mouse model and then an intestinal
inflammation mouse model followed by a spontaneous
resolution phase.
We and others have previously shown that intravenous
infection of S. aureus promotes the accumulation and activation
of IL-10-producing TH17 cells at the intestinal barrier6,7,26.
Mechanistically we showed that the superantigen of S. aureus,
staphylococcus aureus enterotoxin B (SEB), induces a cytokine
storm and rapid induction/expansion of intestinal TH17 cells6.
Here we first immunized the Il17aCre Il10Flox/Flox mice with heat
killed S. aureus and then infected them to test the efficiency of
bacterial clearance (Fig. 2a). We observed that the Il17aCre
Il10Flox/Flox mice had a lower bacterial burden compared to
control mice (Il17aCre Il10Wt/Wt) in the spleen, small intestine
and the liver (Fig. 2b). We also confirmed the frequency and the
number of both TH17 and TH1/TH17 in Il17aCre Il10Flox/Flox mice
were increased after treatment, as already observed under steady
state conditions (Fig. 2c–e). These results suggest that IL-10
deletion in IL-17A producing cells leads to a more efficient
immune response against S. aureus.
IL-10 deletion in TH17 impairs intestinal immune regulation.
Next, we tested whether IL-17A-producing cell derived IL-10 plays
an essential role during the resolution of inflammation in the
small intestine. Thus, we challenged mice with anti-CD3 mono-
clonal antibody (mAb) treatment, a mouse model that we and
others have previously established to induce a transient inflam-
mation in the small intestine followed by the re-establishment of
immunological tolerance6,7,25,27,28. We found that Il17aCre
Il10Flox/Flox mice were more susceptible to inflammation induced
weight loss compared to control mice (Il17aCre Il10Wt/Wt)
(Fig. 3a). Furthermore, the small intestines of the Il17aCre
Il10Flox/Flox mice showed more severe tissue damage, represented
by disrupted villi structures and edema compared to control mice
(Fig. 3b). In addition, we observed a selective accumulation of
TH17 cells and TH17/TH1 cells in the intestine of the Il17aCre
Il10Flox/Flox mice (Fig. 3c–e). We next questioned whether a dif-
ferent expression of IL-10R among the TH17, TH17/TH1 and
TH1 cells could justify the selective accumulation of TH17 cells and
TH17/ TH1 but not of TH1 cells in the Il17aCre Il10Flox/Flox mice. In




















































































































































Fig. 1 TH17 derived IL-10 contributes to intestinal homeostasis. a Tissue distribution of the indicated cell populations within the intestine. Cells were
isolated from indicated intestinal tracts of the Fate+ mice. All cell populations are pre-gated on Foxp3−, YFP+, CD4+ T cells and then described as
TR1exTH17 (IL-10eGFP+ IL17AKata−), IL-10+ TH17 (IL-10eGFP+ IL17AKata+) and TH17 (IL-10eGFP– IL17AKata+) cells on the basis of the reporter molecules. Cell
numbers from three cumulative experiments are used to calculate mean percentage values of the indicated cell populations in different intestinal
compartments. b Heatmap showing normalized mRNA expression value (Z-score) of different cytokines/chemokines in small intestinal tissues. c. Flow
cytometric analysis of small intestinal CD4+ T cells isolated from the indicated mouse lines under steady state. Intracellular staining for both IL-17A and
IFN-γ was then performed to identify TH17 (IL-17A+ IFN-γ−), TH1/TH17 (IL-17A+ IFN-γ+) and TH1 (IL-17A− IFN-γ+) cells. A pre-gate on CD4+ T cells is
applied. d, e Statistical analysis of frequencies (d) and numbers (e) are reported. One representative experiment out of three is shown. Each dot represents
one mouse (nwild type= 4, nKO= 4). Mean ± S.D.; ns, not significant; *P < 0.05 by Mann–Whitney U test. Source data are provided as a Source data file.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-17097-5 ARTICLE










































































































































































































Fig. 2 IL-10 deletion in TH17 enhances antibacterial immunity. TH17 derived IL-10 impairs the development of an efficient immunity against S. aureus. a A
schematic depiction of the experimental plan. b Colony-forming units (CFUs) of S. aureus from different organs. Data are cumulative of two independent
experiments. Each dot represents one mouse (nwild type= 7, nKO= 7). Mean ± SEM.; *P < 0.05 by Mann–Whitney U test. c Flow cytometric analysis of small
intestinal CD4+ T cells after S. aureus infection. Small intestinal lymphocytes were isolated from the indicated mouse lines and intracellular staining for both
IL-17A and IFN-γ was performed to identify TH17 (IL-17A+ IFN-γ−), TH1/TH17 (IL-17A+ IFN-γ+) and TH1 (IL-17A− IFN-γ+) cells. A pre-gate on CD4+ T cell
is applied. One representative experiment out of three is shown. d, e Statistical analysis of frequencies (d) as well as numbers (e) are reported. One
representative experiment out of three is shown. Each dot represents one mouse (nwild type= 5, nKO= 5). Mean ± S.D.; ns, not significant; *P < 0.05 by
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Fig. 3 IL-10 deletion in TH17 impairs intestinal immune regulation. a Percentage of initial body weight after anti-CD3 mAb. The arrows indicate the
injection of anti-CD3 mAb. Data are cumulative of three independent experiments. Mean ± SEM.; *P < 0.05, by two-way ANOVA with Bonferroni’s post
test. b Representative histological pictures of H&E stained small intestines after anti-CD3 mAb treatment. For the statistical analysis on the right, one
representative experiment out of two is shown. Each dot represents one mouse (nwild type= 3, nKO= 3). Mean ± S.D.; *P < 0.05 by Welch’s t-test. c Flow
cytometric analysis of small intestinal CD4+ T cells after anti-CD3 mAb treatment. Small intestinal lymphocytes were isolated from the indicated mouse
lines and intracellular staining for both IL-17A and IFN-γ was performed to identify TH17 (IL-17A+ IFN-γ−), TH1/TH17 (IL-17A+ IFN-γ+) and TH1 (IL-17A−
IFN-γ+) cells. A pre-gate on CD4+ cell is applied. d, e Statistical analysis of frequencies (d) and numbers (e) are shown. One representative experiment
out of three is shown. Each dot represents one mouse (nwild type= 5, nKO= 5). Mean ± S.D.; ns, not significant; **P < 0.01 by Mann–Whitney U test. Source
data are provided as a Source data file.
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TH17 and TH17/TH1 cells express higher levels of IL-10R com-
pared to TH1 cells (Supplementary Fig. 3a, b).
Collectively, these data indicate that the lack of IL-10
expression in IL-17A producing cells promotes immunity against
S. aureus infection, but leads to impaired resolution of the
immune response.
TGF-βRII is required for mature TH17 cells to produce IL-10.
Despite the fact that the molecular signals inducing IL-10 in naïve
CD4+ T cells have been largely explored, the molecular
mechanisms that control IL-10 production in mature TH17 cells
in vivo remain unknown. TGF-β is an obvious candidate con-
sidering its effect on naive CD4+ T cells. To this end, we first
differentiated TH17 cells in vitro, FACS sorted IL-17A producing
CD4+ T cells and then re-stimulated these cells in the presence of
increasing doses of TGF-β. These results confirmed our previous
findings7 and further showed that TGF-β promotes IL-10 pro-
duction also in mature TH17 cells in a concentration-dependent
manner (Supplementary Fig. 4a–d). However, this was an in vitro
experiment and whether this is also the case in vivo remained to
be tested. Therefore, we tested the role of TGF-β on mature TH17
cells using a loss-of-function approach. To this end, we crossed
Tgfbr2Flox/Flox with the Fate+ mice (Supplementary Fig. 5a). This
newly generated Tgfbr2Flox/Flox Fate+ mouse model allowed us to
specifically and selectively delete Tgfbr2 gene in IL-17A-producing
cells, and in the meantime to track the TH17 cell fate as well as
cytokine profile. We first confirmed that the deletion of Tgfbr2
occurs in a TH17-specific manner in Tgfbr2Flox/Flox Fate+ (Sup-
plementary Fig. 5b). Next, we tested whether Tgfbr2-deficient
TH17 cells have any impairment in up-regulating IL-10 expression
when cultured in vitro. We found that both the IL-10+ TH17
population and TR1exTH17 population were reduced in cultured
CD4+ T cells isolated from Tgfbr2Flox/Flox Fate+ mice compared
to CD4+ T cells isolated from littermate controls (Fig. 4a, b). Of
note, we didn’t observe an obvious defect of primary TH17 cell
differentiation with Tgfbr2Flox/Flox Fate+ cells (Supplementary
Fig. 5c, d), which is in line with the previous observation that IL-
17ACre-mediated gene deletion did not affect primary TH17 cell
proliferation and differentiation29.
Finally, we examined whether TH17 cells require TGF-βRII in
order to produce IL-10 in vivo. We observed that under steady
state conditions, intestinal CD4+ T cells marked by YFP
(indicating Tgfbr2 deletion) from Tgfbr2Flox/Flox Fate+ mice had
an obvious impairment in IL-10 and IL-17A production
compared to those cells isolated from Tgfbr2Wt/Wt Fate+ mice
(Supplementary Fig. 5e–g). Since TGF-β promotes the expression
of Foxp3, as a control we tested whether the small expression of
Foxp3+ among the intestinal R26YFP+ CD4+ T cells was
dysregulated in the Tgfbr2Flox/Flox Fate+ mice. However, we did
not observe any statistically significant dysregulation of Foxp3
and more importantly no difference in the number of Foxp3+
YFP+ cells between the Tgfbr2Flox/Flox Fate+ and Tgfbr2Wt/Wt
Fate+ mice (Supplementary Fig. 5h, i).
We then injected anti-CD3 mAb to induce a transient intestinal
inflammation in the small intestine of these mice. Similar to what
we observed by using the Il17aCre Il10Flox/Flox mice, Tgfbr2Flox/Flox
Fate+ were more susceptible to intestinal inflammation compared
to the relative control. The Tgfbr2Flox/Flox Fate+ lost more weight
and had a more severe intestinal pathology than control
Tgfbr2Wt/Wt Fate+ mice (Supplementary Fig. 6a, b). We then
harvested the intestinal tissues and analysed the lymphocyte
composition. We observed that both the frequency and the
amount of IL-10+ TH17 cells and TR1exTH17 cells from the
intestines of Tgfbr2Flox/Flox Fate+ mice were significantly lower
than those from WT Fate+ mice (Fig. 4c–e). Of note, similar to
what is seen under steady state conditions, we did not observe
statistically significant changes in the expression of Foxp3 among
R26YFP+ CD4+ T, nor did we observe differences in the number
of Foxp3+ R26YFP+ cells between the Tgfbr2Flox/Flox Fate+ and
Tgfbr2Wt/Wt Fate+ mice (Supplementary Fig. 6c, d).
To exclude the possibility that reduced IL-10 production from
the CD4+ YFP+ cells of Tgfbr2Flox/Flox Fate+ mice was a
consequence of more severe inflammation, we co-transferred
CD4+ T cells from both CD45.2 Tgfbr2Flox/Flox Fate+ mice and
CD45.1/2 Tgfbr2Wt/Wt Fate+ mice into Rag1−/− mice. After we
engrafted the cells, we injected anti-CD3 mAb and finally harvested
the cells. We found that even when the cells resided in the same
environment, Tgfbr2-deficient TH17 cells lost their ability to express
IL-10 compared to wild-type cells, which still produced IL-10
(Fig. 4f–h). We also observed that Tgfbr2-deficient R26YFP+ TH17
cells expanded and failed to preserve the expression of IL-17A
(Supplementary Fig. 6e), suggesting a role of TGF-β signalling in
controlling proliferation and IL-17A maintenance in this particular
experimental setting. Taken together, these data indicate that
mature TH17 cells intrinsically require signalling via TGF-βRII to
promote the expression of IL-10 in vitro and in vivo.
TGF-β signals via Smad3/4 to regulate IL-10 in TH17 cells. The
next step was to explore the signalling pathway that drives IL-10
expression upon TGF-β engagement with its receptor on mature
TH17 cells. After TGF-β engages its receptor, Smad2 and Smad3
complex is phosphorylated and by binding to either TIF1-γ or
Smad4, translocates into the nucleus to activate gene expression21.
Whether either Smad4 or TIF1-γ controls TGF-β-mediated IL-10
expression in mature TH17 cells remained to be tested.
We first examined the role of TIF1-γ in the expression of IL-10
in TH17 cells. To this end, we made Tif1gFlox/Flox Fate+ mice,
which similar to the Tgfbr2Flox/Flox Fate+ mice described above, in
order to specifically deplete Tif1g in Il17a producing cells
(Supplementary Fig. 7a). After inducing intestinal inflammation
in these mice, we observed that both IL-10+ TH17 cells and
TR1exTH17 cells remain comparable between Tif1gFlox/Flox Fate+
mice and their wild-type littermate controls, suggesting that
TIF1-γ is not required for IL-10 production in TH17 cells in vivo
(Supplementary Fig. 7b–d).
We then evaluated whether Smad4 is important for TGF-β-
mediated IL-10 expression. To address this, we first created
Smad4Flox/Flox Fate+ mice in order to delete Smad4 in TH17 cells
(Supplementary Fig. 8a). Smad4-deficient CD4+ T cells had a
slight, but significant impairment in IL-10 production when
cultured under TH17 conditions in vitro (Supplementary Fig. 8b,
c). These mice were then injected with anti-CD3 mAb and IL-10+
TH17 and TR1exTH17 cell populations were analysed. In line with
the in vitro observations, both types of cells were reduced in the
small intestines of Smad4Flox/Flox Fate+ mice compared with the
wild-type control mice (Fig. 5a–c).
Finally, we also determined the role of Smad3 in regulating IL-
10 production in TH17 cells. We disrupted the function of Smad3
by using either Crispr/Cas9 mediated gene depletion (Fig. 5d, e),
or small chemical inhibitor SIS3 in in vitro differentiated TH17
cells (Supplementary Fig. 9a, b). In both cases, we observed that
the induction of IL-10 in in vitro differentiated TH17 cells by
TGF-β was impaired when Smad3 was deleted/blocked. These
data suggest that Smad3 is also required for TGF-β induced IL-10
production in TH17 cells in vitro.
Taken together, these data show that while TIF1-γ is
dispensable, Smad4 and Smad3 are necessary for TGF-βmediated
IL-10 induction in mature TH17 cells.
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Smad3 and Smad4 activate Il10 transcription in TH17 cells. We
next sought to test whether Smad3 and Smad4 bind to the Il10
promoter in mature TH17 cells. First, we tested whether phospho-
Smad3 translocates into the nucleus shortly after TGF-β stimu-
lation. Nuclear extracts of TH17 cells were immunoblotted and we
observed phospho-Smad3 in the nuclei of these cells (Fig. 6a).
Next, we tested whether Smad3 and Smad4 are able to induce Il10
gene transcription. We first cloned Il10 proximal promoter
(−1444 to +1) in the pGL2 vector upstream of Luciferase
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Fig. 4 TGF-βRII is required for mature TH17 cells to produce IL-10. a Flow cytometric analysis of in vitro cultured total CD4+ T cells. Cells were polarized
under TH17 condition for 5 days. A pre-gate on viable (DAPI−), CD4+ T cell population is applied. b Statistical analysis of IL-10+ TH17 and TR1exTH17 cells is
shown by one representative experiment out of three. Each dot represents one mouse (nwild type= 3, nKO= 5). Mean ± S.D.; *P < 0.05, ***P < 0.001 by
Welch’s t-test. c Flow cytometric analysis of small intestinal CD4+ T cells after anti-CD3 mAb treatment. The indicated reporter mouse lines were used.
Top panels are pre-gated on Foxp3− CD4+ T cells. Bottom panels are gated on YFP+ cells, as shown, and the indicated populations are identified on
the basis of the reporter molecules as follows: TR1exTH17 cells: IL-10eGFP+ IL-17aKata−; IL-10+ TH17 cells: IL-10eGFP+ IL-17aKata+; TH17 cells: IL-10eGFP– IL-
17aKata+. d, e Frequencies (d) and numbers (e) of the indicated populations are shown. One representative experiment out of three is shown. Each dot
represents one mouse (nwild type= 5, nKO= 5). Mean ± S.D.; ns, not significant; *P < 0.05, **P < 0.01 by Mann–Whitney U test. f. Experimental design for
Co-transfer of total CD4+ T cells isolated from wild-type Fate+ mouse and Tgfbr2Flox/Flox Fate+ mouse lines. g. Flow cytometric analysis of small intestinal
co-transferred CD4+ T cells after anti-CD3 mAb treatment. Small intestinal lymphocytes were isolated from the indicated mouse lines and intracellular
staining was then performed to identify the indicated cell populations in combination with reporter molecules for IL-10 (eGFP) and IL-17a lineage (YFP). All
cell populations are pre-gated on CD4+ T cells. h Frequencies of TR1exTH17 and IL-10+ TH17 in G is shown by one representative experiment out of two.
Each dot represents one recipient mouse (n= 3). Mean ± S.D.; *P < 0.05, ***P < 0.001 by Welch’s t-test. Source data are provided as a Source data file.
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pCMVβ mammalian expression vectors respectively. Co-
transfection of Il10 proximal promoter with increasing con-
centrations of either only Smad3 or only Smad4 expression
plasmids did not result in significant upregulation of luciferase
activity. However, when increasing concentrations of Smad4
plasmid were co-transfected with a constant amount of Smad3
plasmid, a significant increase in Il10-luciferase activity was
observed (Fig. 6b). These data suggest that Smad3 and Smad4-
synergistically activate the Il10 promoter.
In order to show that Smad3 and Smad4 directly bind the Il10
promoter in mature TH17 cells, we performed Chromatin
Immunoprecipitation (ChIP) experiments with FACS sorted
TH17 cells stimulated with or without TGF-β for 30 min. We
found that 30 min after TGF-β treatment, both Smad3 and Smad4
accessed and bound the Il10 promoter on the −929/−756
element. Of note, between −929/−756 and −286/−283 base pairs
on Il10 promoter lie predicted Smad3/4 binding sites (Fig. 6c). As
a negative control, we interrogated the GAPDH TATA box
promoter region where Smad3 and Smad4 proteins do not bind,
and as expected we did not see any signal. Finally, in order to
show that Smad3 and Smad4 proteins form a complex in TH17
cells, we performed Proximity Ligation Assay (PLA) in FACS
sorted TH17 challenged for 30 min with TGF-β, using a plus and a
minus ligation probe specific for anti-mouse Smad3 and anti-
rabbit Smad4 antibodies, respectively. Confocal microscopic
images reveal that the Smad3/4 complexes are only visible in
the nucleus of TH17 cells challenged with TGF-β (Fig. 6d).
Interestingly, this protein complex forms 3–5 bright, closely
spaced foci per cell. The PLA spots were located in the rim of the
TH17 cell nucleus associated with the nuclear membrane. Taken
together, these results show that Smad3 and Smad4 proteins are
instructed by TGF-β signal, form a nuclear complex that bind to
the proximal Il10 promoter and transactivates Il10 transcription
in TH17 cells.
TGF-β promotes IL-10 expression in human TH17 cells. We
tested whether human TH17 cells isolated from the intestine can
also produce IL-10. We observed that a small but consistent
frequency of CD4+ T cells isolated from healthy colon tissues
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IL-6, IL-23 and TGF-β
NT, #1 Smad3, #2
Fig. 5 TGF-β signals via Smad3/4 to regulate IL-10 in TH17 cells. a Flow cytometric analysis of small intestinal CD4+ T cells after anti-CD3 mAb. The
indicated reporter mouse lines were used. Top panels are pre-gated on Foxp3−, CD4+ T cells. Bottom panels are pre-gated on YFP+ cells, and the indicated
populations are identified on the basis of the reporter molecules as follows: TR1exTH17 cells: IL-10eGFP+ IL-17aKata−; IL-10+ TH17 cells: IL-10eGFP+ IL-17aKata+;
TH17 cells: IL-10eGFP− IL-17aKata+. b, c Frequencies (b) and numbers (c) of TR1exTH17, IL-10+ TH17 and TH17 cells in A are one representative experiment
out of three. Each dot represents one mouse (nwild type= 5, nKO= 5). Mean ± S.D.; ns, not significant; *P < 0.05, **P < 0.01 by Mann-–Whitney U test.
d Experimental design of knocking out Smad3 in in vitro differentiated mature TH17 cells by using CRISPR/Cas9 technology. e Flow cytometric analysis of
in vitro cultured mature TH17 cells after knocking out Smad3 by using gRNAs targeting Smad3. Cells were pre-gated on viable CD4+ T cells. NT, non-
targeting control. Each dot represents an individual gRNA (nNT= 2, nSmad3= 3). Mean ± S.D.; **P < 0.01 by Welch’s t-test. Source data are provided as a
Source data file.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-17097-5 ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:3334 | https://doi.org/10.1038/s41467-020-17097-5 |www.nature.com/naturecommunications 7
Next, we wondered whether human TH17 cells can also acquire
the expression of IL-10 when stimulated with TGF-β. We
therefore isolated circulating CD45RAlow CD25− IL-17A+
(TH17) cells from human blood using the IL-17A secretion assay
and cultured the isolated TH17 cells in the presence of increasing
TGF-β concentrations. The purity of the TH17 cells isolated from
human blood was always more than 95% (for a representative
purity plot see Supplementary Fig. 10a). Upon examining the
CD4+ Foxp3− T cell compartment (see Supplementary Fig. 10b
for the gating strategy), we observed that approximately half of
the sorted cells, that were formerly IL-17A+, ceased to produce
IL-17A (i.e. they become exTH17 cells) while the other half
retained IL-17A expression. However, this phenomenon was not
affected by TGF-β (Fig. 7b). In contrast, TGF-β promoted IL-10
expression in both TH17 cells and exTH17 cells in a
concentration-dependent manner (Fig. 7b). Finally, increasing
TGF-β concentrations appeared to slightly reduce the frequency
and the numbers of IL17A+ IFN-γ+ and IFN-γ+ producing cells
(Supplementary Fig. 10c, d). Furthermore, increasing the TGF-β
concentrations did not have a reproducible effect on Foxp3
expression in human peripheral blood-isolated TH17 cells (Sup-
plementary Fig. 10e). Collectively, these results show that human
a









































































































































Fig. 6 Smad3 and Smad4 activate Il10 transcription in TH17 cells. aWestern blot of TH17 cell-total/nuclear extracts challenged with or without TGF-β for
30min. One representative experiment out of two is shown. b Schematic representation of the proximal murine Il10 promoter (from −1444 to +1 bp)
driving the expression of the luciferase reporter gene (luc). The predicted binding sites for Smad3 and Smad4 as well as the Il10 TSS are depicted (top).
Relative Luc activity driven by Smad3 and Smad4 on proximal Il10 promoter (bottom). Mean ± SEM (n= 3). *P < 0.05, **P < 0.01, and ***P < 0.001 by
ordinary two-way ANOVA and Tukey’s multiple comparisons test. c Schematic representation of the proximal murine Il10 promoter (from −1444 to +1 bp)
indicating the predicted binding sites for Smad3 and Smad4 and the depicted amplicons A (from −416 to −278 bp), B (from −929 to −756 bp), and C
(from −365 to −171 bp) (top) that were used to amplify the chromatin Immunoprecipitated DNA. Smad3 and Smad4 Chromatin immunoprecipitation
(ChIP) of sorted TH17 cells challenged with or without TGF-β (bottom). One representative experiment out of three is shown. d Proximity Ligation Assay
(PLA) using sorted TH17 cells challenged with or without TGF-β. White arrows indicate positive Smad3/Smad4 interaction signal (red dots) superimposed
on nuclei stained with DAPI (blue). Scale bar represents 10 μm. Number of PLA spots per cell and the number of PLA positive cells are reported in the box.
One representative experiment out of two is shown. ***P < 0.001 for comparison by χ2 test. Source data are provided as a Source data file.
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TH17 cells from the intestine and from peripheral blood, are able
to produce IL-10 and furthermore, that TGF-β is able to promote
dose dependent IL-10 expression in human peripheral blood
derived TH17 cells.
Discussion
TH17 cells are usually found in the inflamed tissues of IMID
patients such as the central nervous system, the kidney, the joints
and the heart. However, they are also abundant in the small
intestine of healthy individuals without causing any overt dis-
eases30–32. The TH17 cell plastic behaviour allowing them to
acquire both pro- and anti-inflammatory fate can explain such
ubiquitous presence and consequences: pathological or physio-
logical. Our data show that it is in fact mainly in the ileum and
Peyer’s patches of mice where these cells acquire their anti-
inflammatory fate. This suggests that continuous plasticity from
TH17 cells to IL-10 producing TH17 cells and possibly to
TR1exTH17 cells impairs the pathogenic immune reaction of
effector TH17 cells in the intestinal tract. Supporting this, when
TH17 cell-derived IL-10 is lacking, the cellular and molecular
immune homeostasis of the intestine is disturbed, showing the
relevance of the anti-inflammatory fate of these cells. This effect is
remarkable considering that only a relatively small fraction of
TH17 cells acquire an anti-inflammatory function. Finally, our
data show that also human TH17 cells acquire the regulatory
phenotype when exposed to TGF-β1.
Despite the above, we did not observe macroscopic tissue damage
in the Il17aCre Il10Flox/Flox mice. One explanation is the compen-
satory mechanism which could be exerted by the presence of other
regulatory T cells, such as Foxp3+ Treg cells and TR1 cells able to
produce IL-1023,25. Indeed, it has to be considered that only a
fraction of TR1 cells originate from the TH17 cells, while the rest
originate from other cells, including probably TH1 cells33. Thus, the
latter TR1 cell fraction is still functional in this mouse model.
Another explanation is the composition of the intestinal microbiota
of our mice. It is possible that under different specific pathogen free
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Fig. 7 TGF-β promotes IL-10 expression in human TH17 cells. a Two representative dot plots of CD4+ T cells extracted from healthy human colonic
tissue, stained intracellularly for IL-17A and IL-10. The diagrams show the frequencies of IL-17A+/IL-10+ within the TH17 cells (left) and within the total
CD4+ T cell (right) (n= 14) b Representative dot plots of TH17 cells isolated from human blood donor, stimulated and cultured under increasing TGF-β1
concentrations for 5 days and finally stained for IL-17A and IL-10 intracellularly. The graphs below show the percentages of IL-17A+/IL-10−, IL-17A+/IL-10+
and IL-17A−/IL-10+ cells from four different blood donors. P values were calculated between the lowest TGF-β and highest TGF-β concentration conditions
by Mann–Whitney U test (n= 4). Source data are provided as a Source data file.
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Interestingly, we observed a specific expansion of intestinal
TH17 and TH1/TH17 cells, but not of TH1 cells in our Il17aCre
Il10Flox/Flox mouse model. One possible explanation of this cell-
selective control mediated by IL-10 is that both TH17 and TH1/
TH17 cells express higher level of IL-10R compared to TH1 cells.
Alternatively, one could consider that this is due to a dysregu-
lation of Rorgt+ Foxp3+ Treg cells in Il17aCre Il10Flox/Flox. These
cells are indeed known to be able to specifically regulate TH17
cells, especially in the colon34. However, only a small fraction of
Il17aCre-activated cells are Foxp3+ and the large majority of
Rorgt+ Foxp3+ Treg cells are known to express little to no IL-
17A and thus are not mainly affected in the small intestine of the
Il17aCre Il10Flox/Flox mice35,36. Therefore, these data suggest that a
possible dysregulation of Rorgt+ Foxp3+ Treg cells is not the
explanation for the selective increases in the number of TH17 cells
observed in this study.
TH17 cells also play a key role in mediating host defence
against bacteria1. Through evolution, pathogens have developed
mechanisms to evade the immune system of the host. For
example, it was shown in mice and humans that S. aureus, a
nosocomial and potentially multi drug resistant bacteria, pro-
motes the anti-inflammatory fate of TH17 cells7,26. Our data add
to this because they show that the TH17 cell anti-inflammatory
fate can indeed favour dissemination of the pathogens. Given that
this anti-inflammatory fate has been preserved throughout evo-
lution, we wondered what its benefit is, and at what cost it comes.
Considering that S. aureus bacteria only becomes a lethal threat
when it disseminates through the blood stream, we propose that
the benefit is the TH17 cell anti-inflammatory fate’s ability to
constantly maintain the immune homeostasis. We also propose
that the cost of the TH17 cell anti-inflammatory fate is rather low,
considering that occurrence of a bacterial infection through the
blood is relatively unlikely.
The role of TGF-β during the differentiation of TH17 cells has
been widely studied and also debated9,37. It is currently accepted
that TGF-β is sufficient, but not necessary for the induction of
these cells and in addition, that it favours the development of
TH17 with regulatory potential. Our experiments aimed to
expand the understanding of TGF-β function from the early
differentiation phase to the effector phase of TH17 cell biology.
We showed for the first time directly in vivo that Tgfbr2-deficient
TH17 cells had an impaired capacity to produce IL-10. In addi-
tion, the Tgfbr2Flox/Flox Fate+ mice phenocopied the impairment
in immune regulation observed in the Il17aCre Il10Flox/Flox mice.
These results broaden the state of knowledge of TGF-β, revealing
the role of TGF-β in plasticity and function of TH17 cells upon
maturation.
Furthermore, we noticed that under steady state conditions and
after anti-CD3 mAb treatment, the frequency of YFP+ cells
increase when TGF-βRII signalling is impaired. This suggests that
the expansion of TH17 cells, which could otherwise lead to
pathogenicity, is controlled by TGF-β. This is in line with the
known anti-proliferative effect of TGF-β on CD4+ T cells38.
Furthermore, we observed that the large majority of TGF-βRII
deficient YFP+ cells lose the expression of IL-17A under steady
state conditions and upon transfer into Rag1−/− mice, while they
maintain the expression of IL-17A during intestinal inflamma-
tion. On the one hand, this is in keeping with the concept of a
“sufficient but not necessary” role of TGF-β during the differ-
entiation of TH17 cells: under certain conditions, TGF-β is
necessary to maintain IL-17A expression, but during inflamma-
tion it becomes unnecessary. On the other hand, this also suggests
that the fraction of TH17 cells which do lose IL-17A, but express
IL-10 in wild type mice during inflammation have restrained the
TGF-β signalling towards Smad3/Il10 thus avoiding the re-
activation of RORγt/IL-17A pathway. It has indeed been shown
that TGF-β blocks RORγt activity via Smad319 and that TGF-β
can restrain IL-17A by a post-translational deubiquitination of
RORγt28.
Of note, TGF-β appears to impact IL-10 production also in
other effector CD4+ T cells such as TH1 cells, although the
current evidence is controversial. For example, TGF-β has been
shown to inhibit IL-10 production in TH1 cells by blocking the
expression of Blimp-139, while others reported a positive effect of
TGF-β on IL-10 production by TH1 cells40,41. Therefore, TGF-β
seems to have different effects on TH1 and TH17 cells regarding
IL-10 production, but further in vivo studies on TH1 cells are
required to confirm this.
Downstream of TGF-β receptor, our results suggest that the
canonical TGF-β mediators Smad3 and Smad4—but not TIF1-γ
—promote the expression of IL-10 in mature TH17 cells.
Apparently in contrast to our data, it has been shown that TIF1-γ
blocks the expression of IL-10 in CD4+ T cells while differ-
entiating into TH17 cells22. However, while this study used the
CD4Cre Tif1gFlox/Flox mouse model, we used an Il17ACre
Tif1gFlox/Flox mouse model instead. One possible explanation is
that during TH17 cell differentiation, TIF1-γ constrains IL-10
expression by obstructing Smad-recognized cis-elements from the
Smad4-Smad2/3 complexes, and that this becomes dispensable in
mature TH17 cells when the Il10 gene is already accessible. In
keeping with the different function of TIF1-γ in the two different
phases, this is also evident regarding the regulation of IL-17A
expression: TIF1-γ plays a key role in the expression of IL-17A
during TH17 cell differentiation22. However, our data suggest that
its deletion in mature TH17 cells becomes dispensable for IL-17A
expression. Therefore, these datasets are -probably- not incom-
patible with each other, but rather they reveal different molecular
mechanisms operating during the differentiation and maturation
phases of TH17 cells.
Cell clones of blood derived human TH17 cells are capable of
acquiring the expression of IL-10 in vitro26. In line with this data,
here we show that human primary TH17 cells are also able to
produce IL-10 and are present in the human intestine. It has
recently been suggested that IL-27 promotes the expression of IL-
10, via the transcription factor c-Maf, in human TH17 clones16.
However, whether IL-27 alone or in combination with TGF-β can
also induce the expression of IL-10 in freshly isolated human
TH17 cells remains to be tested. Nevertheless, our data serve as
proof of principle to show that it is possible to turn freshly iso-
lated human TH17 cells into IL-10 producer cells.
The transcription factor Blimp1 has also been proposed as
being able to promote the conversion of TH17 cells into
TR1 cells14. However, it is also known that TGF-β blocks Blimp1
activation39,42. Because of this, we did not investigate the role of
Blimp1 in our system. However, our data do not exclude a role of
Blimp1 in the anti-inflammatory fate of TH17 cells and it could be
possible that TGF-β and IL-27 are two complementary pathways
to induce the conversion of TH17 cells into TR1 cells in different
microenvironments.
Collectively, our data show that the anti-inflammatory fate of
TH17 cells is not a mere consequence of immune homeostasis, but
that it actually plays an indispensable role in the maintenance of
this equilibrium. TGF-β mediates the expression of IL-10 via
Smad3 and Smad4 and consequently, it is the fundamental
environmental signal to tighten the balance between the pro- and
anti-inflammatory fates of mature TH17 cells. We propose that
the TH17 cell plasticity between pro and anti-inflammatory fates
is a key feature of immune system adaptation and when impaired,
immunity and tissue integrity are compromised. Exploring the
molecular mechanisms of this biological phenomena will help to
identify therapeutic targets, such as Smad3 and Smad4 for new
therapies that aim to steer the immune response according to the
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clinical need, rather than globally suppress it, as the majority of
the current therapies have been based upon.
Methods
Mice. C57BL/6 Rag1−/− mice (Stock #: 002216) and Rosa26-Cas9 knock-in mice
(Stock #: 028555) were purchased from the Jackson Laboratories. Il10Flox/Flox mice
(kindly provided by Axel Roers) were further crossed with Il17ACre mice (kindly
provided by Dr. Brigitta Stockinger). Tgfbr2Flox/Flox (purchased from JAX, Stock #:
012603), Smad4Flox/Flox (kindly provided Dr. Elizabeth Robertson43) and
Tif1gFlox/Flox (kindly provided by Dr. Vesa Kaartinen44) mice were further crossed
with Fate+ mice (Foxp3RFP, Il10eGFP, Il17ACRE/Katushka, R26YFP, as described
before7) to generate Tgfbr2Flox/Flox Fate+ (Tgfbr2Flox/Flox, Foxp3RFP, Il10eGFP,
Il17ACRE/Katushka, R26YFP), Smad4 Flox/Flox Fate+ (Smad4Flox/Flox, Foxp3RFP,
Il10eGFP, Il17ACRE/Katushka, R26YFP) and Tif1g Flox/Flox Fate+ (Tif1gFlox/Flox,
Foxp3RFP, Il10eGFP, Il17ACRE/Katushka, R26YFP) mice. In these models, cells
expressing a high level of Il17a activate the CRE recombinase to delete the stop
sequence 5′ to YFP and to deplete Tgfbr2, Smad4 or Tif1g. Thus, such IL-17A-
expressing cells are permanently marked by YFP and in the meantime, lose the
expression of Tgfbr2, Smad4 or Tif1g genes. All mice were kept under specific
pathogen-free (SPF) conditions, on a 12/12 on/off light cycle, maintained at 72
(+/−2) °F with 70% humidity in the animal facility at Yale University. Age- and
sex-matched littermates between 8 to 24 weeks of age were used for experiments.
Unless they came with special instructions, mice were randomly assigned to dif-
ferent experimental groups and each cage contained animals of all different
experimental groups. Both male and female mice were used in experiments. Ani-
mal procedures were approved by the Institutional Animal Care and Use Com-
mittee (IACUC) of Yale University. Preliminary experiments were tested to
determine sample sizes, taking available recourses and ethical use into account.
Anti-CD3 mAb treatment and intestinal histology. Anti-CD3 mAb (Clone #:
2C11) were injected intra-peritoneally three times (15, 15, and 30 μg per mouse)
every other day. Mice were euthanised with CO2 24 h after the last injection.
Different parts of small intestines (duodenum, jejunum and ileum) were fixed in
Bouin’s Fixative Solutions for 1 h. Tissues were then embedded in paraffin for
sectioning. Pictures were taken by optical microscope equipped with camera sys-
tems and analysed.
Lymphocyte isolation from mouse small intestine. Methods were described
before in detail45. Basically, intestinal tissues were first digested in 1 mM DTE at
37 °C for 30 min to get the IEL fraction. Remaining tissues were then digested in 1
mg/ml collagenase from Clostridium Histolyticum at 37 °C for another 30 min to
get the LPL fraction. Both fractions were further applied with Percol gradient
centrifugation to enrich lymphocyte populations.
Flow cytometry antibodies and intracellular cytokine staining. Mouse T cells
were stained with monoclonal antibodies to CD4 (GK1.5, Cat # 100428 or RM4-5
Cat # 100536), CD8 (53-6.7 Cat # 100722), NK1.1 (PK136 Cat # 108713), CD19
(6D5 Cat # 115508), CD11b (M1/70 Cat # 101216), CD11c (N418 Cat # 117318),
γδTCR (GL3 Cat # 118123), TGFβRII (R&D Systems Cat # FAB532P). All anti-
bodies without further instructions are purchased from eBiolegend and diluted
1:200 for staining at 4 °C. Importantly, TGFβRII staining was performed at 37 °C
for 30 min with 1:50 dilution. Although in the figure legends we referred only to
CD4+ T cells, in each FACS related experiment we specifically analysed CD4+
T cells CD8−, NK1.1−, CD19−, CD11b−, CD11c−, γδTCR−. For intracellular
cytokine staining, the cells were re-stimulated for 3 h at 37 °C with phorbol
12-myristate 13-acetate (PMA) (Sigma, 50 ng ml−1) and ionomycin (Sigma, 1 μg
ml−1) in the presence of Golgistop (BD Bioscience). Cells were then fixed in 3.7%
formaldehyde for 20 min at room temperature. After washing, the cells were then
permeabilized in 0.1% NP40 and stained at 37 °C with anti-IL-17A (TC11-18H10.1
Cat # 506925), anti-IFNγ (BD Bioscience, Cat # 554412) antibodies for 30 min with
1:200 dilution. Lymphocytes were re-suspended in PBS, 0.5% FBS, 5 mM EDTA
and acquired with an LSRII cytometer (BD Bioscience).
Staphylococcus aureus infections. Heat-inactivated S. aureus (ATCC 14458,
SEB+ TSST-1-) was injected intravenously (1 × 107 colony forming units per
mouse) into 4-week-old mice for immunization purposes. Three weeks later, the
mice were injected intravenously again with 1 × 106 live S. aureus bacteria. Mice
were euthanised with CO2 1 week after the 2nd injection, when they displayed
clinical symptoms of sepsis. Different organs were then harvested to examine the
colony forming unit (CFU) of S. aureus. T cells isolated from intestines were
further analyzed by FACS.
Plasmids and transfections. The coding sequences for Smad3 and Smad4 were
cloned via reverse transcription and PCR from murine C57BL/6 splenic leukocytes
total RNA with the appropriate primers, Superscript III reverse transcriptase (Invi-
trogen) and Phusion® Hot Start Flex DNA polymerase (New England Biolabs). The
PCR products were cloned in pGEM®-T Easy vector (Promega) and were subse-
quently sub-cloned into pCMVTNT™ (Promega) and pCMV-Tag2 (Agilent
Technologies) mammalian expression vectors respectively, using the appropriate
primers and the InFusion ligation system (Takara). The Il10 proximal promoter
(from −1444 to +1 bp) was cloned via PCR from C57BL/6 genomic DNA with
appropriate primers and was subcloned into pGL2 vector (Clontech) using the
InFusion ligation system (Takara) and appropriate primer sets. Transfections were
performed in HEK293T cells with the BES buffered saline/CaCl2 method. Briefly,
expression and reporter plasmid mixes were left to precipitate for 20min at room
temperature, in a solution containing 0.125M CaCl2, 0.025M BES, 0.02 NaCl,
0.00075 NaH2PO4, pH:6.95. The precipitated plasmid mix was overlaid carefully on
the HEK293T cell DMEM 10% FBS culture medium. In all, 24 h later the transfection
medium was aspirated and fresh DMEM 10% FBS was placed onto the HEK293T
cells. Cells were collected 48 h after transfection, washed twice with PBS and lysed in
Passive Lysis Buffer (Promega). Luciferase activity was determined using the Luci-
ferase Assay System (Promega) and was measured in a FluoStar Omega reader and
Software. Transfection efficiency was determined by spiking all transfections with 0.5
ng pCMV-EGFP vector (Clontech) and measuring GFP activity in the lysates.
TH17 cell differentiation and immunoblot. Briefly, naïve CD4+ T cells were
isolated from the spleen and lymph nodes of 4–6 mice of the indicated transgenic
mouse strains with the mouse naïve CD4+ T cell isolation Kit (Stemcell). The cells
were cultured for five days under TH17 polarizing conditions, in Click’s medium
supplemented with 5% FBS, 0,1 mM β-merkaptoethanol, Glutamax™ (Gibco), 100
U/mL Penicillin/Streptomycin, 10 μg/mL anti-CD3, 2 μg/mL anti-CD28, 10 μg/mL
anti-IFNγ, 10 μg/mL anti-IL-4, 20 ng/mL murine IL-23, 20 ng/mL murine IL-6, 0.5
ng/mL murine TGF-β1 (unless specially indicated). TH17 cells were sorted based
on the IL-17A reporter expression resuspended into 2 × 106 cells/mL and then
challenged with or without TGF-β for 30′min. Subsequently the cells were lysed
and either total or nuclear extracts were obtained and loaded on 4–15% precast
acrylamide gels (Mini-PROTEAN, BIO-RAD). After electrophoresis the proteins
were transferred to PVDF membranes. The membranes were immunoblotted with
the indicated antibodies and developed according to standard protocols. We loaded
the protein extract equivalent corresponding to 8 × 105 TH17 cells in each well.
Retroviral preparation and transduction. For retroviral preparation, 1 μg of
individual Smad3 sgRNA vector with 0.5 μg of EcoHelp plasmid were employed to
transfect HEK293T cells. In all, 12 h later, media was replaced and virus was grown
for another 48 h. Supernatant containing virus was collected and polybrene was
added to achieve a final concentration of 4 μg/ml. For retroviral transduction,
Cas9-expressing T cells were first activated for 24 h and then spin transduced with
viral supernatant.
Chromatin Immunoprecipitation. Rested TH17 cells were challenged or not with
1 μg/mL TGF-β1 for 30 min. The cells were fixed with 1.1% Formaldehyde for 10
min, washed, and re-suspended in 10 mM Tris pH:7.5, 10 mM NaCl, 3 mM MgCl2,
1 mM CaCl2, 4% NP40 supplemented with protease inhibitors, at a final con-
centration of 4 × 107 cells/mL. Subsequently, 0.2 units MNase (Sigma) were added
for 5 min at 37 °C, followed by 3 mM EGTA and the cells were centrifuged at 500 g
and re-suspended in 50 mM Hepes pH:7.9, 150 mM NaCl, 5 mM EDTA, 0.5 mM
EGTA, 0.1%SDS, 0.1% Na-deoxycholate, supplemented with protease inhibitors
and sonicated 3 times for 20 sec. 1% Triton X-100 was added and the samples were
centrifuged for 15000 g for 15 min at 4 °C. The lysates were extensively dialysed in
10 mM Tris pH: 7.5, 5% glycerol, 1 mM EDTA, 0.5 mM EGTA. For immunopre-
cipitation, TH17 cell lysates were incubated o/n with designated antibodies and the
next day were mixed with Dynabeads™ Protein G (Invitrogen, #00374128) in
RIPA buffer for 4 h at 4 °C. The beads were washed in low (150 mM NaCl),
high (500 mM NaCl) and LiCl (250 mM) salt buffer, the crosslinks were reversed at
65 °C, the samples were purified by Phenol/Chlorophorm extraction, the DNA was
precipitated and used in q-PCR reactions.
Real-time quantitative PCR. qPCR was performed using chromatin immuno-
precipitation reactions with the anti-Smad3 and Smad4 and isotype control anti-
bodies, along with the indicated primers and KAPA SYBR FAST qPCR Kit (Kapa
Biosystems, Wilmington, MA) in a StepOne cycler (Applied Biosystems, Carlsbad,
CA). The CT values from triplicate qPCR reactions were extracted from the Ste-
pOne cycler (Applied Biosystems, Carlsbad, CA) onto spreadsheets and were
analyzed with the relative quantification method 2–ΔΔCT. The abundance level of a
given amplicon per sample/condition was determined relative to its input (non-
enriched) chromatin abundance and was additionally corrected relative to isotype
control antibody immunoprecipitation sample.
Proximity ligation assay. In vitro differentiated sorted TH17 cells were rested for
5 days in Click’s medium supplemented with 2 ng/mL murine IL-2 (PeproTech
#212-12) and were subsequently challenged with 1 μg/mL human TGF-β1 for 30
min. Subsequently, the cells were washed, re-suspended in a minimal volume of
PBS supplemented with 10% FBS 0.3% BSA, overlaid onto coverslips and were left
to dry for 12 h. The cells were rehydrated with PBS, fixed with 4%PFA and per-
meabilized with 0.3% PBS-Triton X100. After washing, the specimens were
blocked, incubated with pospho-Smad3 and Smad4 antibodies and stained with
Duolink® In Situ detection Reagents Red (Sigma). After mounting, the slides were
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analysed by confocal microscopy and the acquired images were opened and pro-
cessed with Fiji software (Image J).
Lymphocyte isolation from human intestine. The human colonic tissue is
derived from colon cancer patients admitted into the UKE General Surgery Clinic.
The study was approved by the Ethical Physicians Committee of Hamburg (Ethik-
Kommision der Aertztekammer Hamburg) and Informed Written Consent was
obtained from each one of the sample donors. The general characteristics of the
participants cohort were five males and nine females with an average age of 69,5
years (±SD= 11 y) Healthy tissues adjacent to the tumor, were collected by col-
laborating surgical personnel, immediately after the completion of the surgical
procedure. Next, the tissue samples were processed for lymphocyte isolation.
Intraepithelial lymphocytes were isolated by digesting the tissue with Dithiothreitol
(DTT Sigma-Aldrich) solution at 37 °C for 20 min, followed by incubation with
collagenase IV (100 U; Sigma-Aldrich) for 30 min at 37 °C. The cells were further
separated by a Percoll gradient (GE Healthcare). After this the cells were stained
for FACS analysis. Only the healthy colonic tissue data analysis with respect to
CD4+FOXP3−IL17A+ and IL-10+ cell compartment is presented in this manu-
script. For a comprehensive description of the patients, please refer to the
Source data file of Supplementary Fig. 9e. Part of the human cohort analyzed in this
study was also used for assessing the expression of IL-22 in Perez et al.46.
Sorting of humanTH17 cells from Buffy Coat. Enriched human Buffy Coat sam-
ples retrieved directly from the UKE Transfusion Medicine, were diluted with PBS to
a total volume of 350mL. The diluted blood samples were overlaid to buffered Biocoll
separating solution (Merck, #L6715) and centrifuged at 300 g for 20min. The PBMCs
were collected, washed with PBS and stimulated for 3 h with 50 ng/mL PMA and 1μΜ
Ionomycin. CD4+ T cells were selected with magnetic human CD4 microbeads
(#130-045-101, Miltenyi, Bergisch-Gladbach, Germany). IL-17+ cells were stained
with the IL17A secretion assay detection kit (#130-094-537, Miltenyi, Bergisch-
Gladbach Germany) and with human anti-CD4/FITC, anti-CD45RA/Alexa700, anti-
CD127/PE.Cy7 and anti-CD25/BV650 and sorted with an Aria Illusion instrument
(BD Bioscience). In all, 5–8 × 103 sorted CD4+ IL-17A+ CD45RA−CD127−CD25−
cells were rested in RPMI medium (supplemented with 10% FBS, 10mM β-mer-
kaptoethanol, Glutamax, Penicillin/Streptomycin 100 U/mL) plus 2 ng/mL IL-2
(PeproTech). After 48 h the cells were challenged with increasing concentrations of
TGF-β1 for five days. Subsequently, cells were stimulated with PMA/Ionomycin,
stained for CD4, IL-17A, and IL-10 expression and analysed by FACS.
Statistics. FACS data were visualized and analyzed with FlowJo 10.5.3 (BD
Bioscience). Statistical analyses were calculated in Prism (Graphpad Software).
According to the experimental set-up we used Mann–Whitney U test or Welch’s
t-test (Data specified in Figs. 1–5), two-way ANOVA (Fig. 6b) and χ2 test (Fig. 6d).
The p values presented in Fig. 7 were calculated via the Mann–Whitney U test. The
specific statistical analyses used in each figure are further described in the figure
legends. When not otherwise specified, the statistical test used is always two-sided.
p < 0.05 was considered significant.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
We declare that the data supporting the findings of this study are available within the
paper (and its Supplementary Information files). Source data are provided with
this paper.
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